These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21436765)

  • 1. Massive insulin overdose managed by monitoring daily insulin levels.
    Mork TA; Killeen CT; Patel NK; Dohnal JM; Karydes HC; Leikin JB
    Am J Ther; 2011 Sep; 18(5):e162-6. PubMed ID: 21436765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lantus insulin overdose: a case report.
    Lu M; Inboriboon PC
    J Emerg Med; 2011 Oct; 41(4):374-7. PubMed ID: 20493654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide for the treatment of hypoglycemia after insulin glargine overdose.
    Groth CM; Banzon ER
    J Emerg Med; 2013 Aug; 45(2):194-8. PubMed ID: 23669130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lantus overdose: case presentation and management options.
    Fuller ET; Miller MA; Kaylor DW; Janke C
    J Emerg Med; 2009 Jan; 36(1):26-9. PubMed ID: 17976762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attempted suicide by massive insulin injection: a case report and review of the literature.
    Thewjitcharoen Y; Lekpittaya N; Himathongkam T
    J Med Assoc Thai; 2008 Dec; 91(12):1920-4. PubMed ID: 19133531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged glucose requirements after intentional glargine and aspart overdose.
    Fromont I; Benhaim D; Ottomani A; Valéro R; Molines L; Vialettes B
    Diabetes Metab; 2007 Nov; 33(5):390-2. PubMed ID: 17644447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin degludec overdose may lead to long-lasting hypoglycaemia through its markedly prolonged half-life.
    Uchida J; Oikawa Y; Katsuki T; Takeda H; Shimada A; Kawai T
    Diabet Med; 2018 Feb; 35(2):277-280. PubMed ID: 29178371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosing of insulin glargine in the treatment of type 2 diabetes.
    Barnett A
    Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intentional overdose with insulin glargine and insulin aspart.
    Tofade TS; Liles EA
    Pharmacotherapy; 2004 Oct; 24(10):1412-8. PubMed ID: 15628838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
    Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
    Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
    Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
    Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing hyperglycemia from hospital admission to discharge.
    Moghissi ES
    Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poisoning with insulin glargine.
    Brvar M; Mozina M; Bunc M
    Clin Toxicol (Phila); 2005; 43(3):219-20. PubMed ID: 15902802
    [No Abstract]   [Full Text] [Related]  

  • 15. Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients.
    Chant C; Wilson G; Friedrich JO
    Pharmacotherapy; 2005 Mar; 25(3):352-9. PubMed ID: 15843282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid onset of glycogen storage hepatomegaly in a type-2 diabetic patient after a massive dose of long-acting insulin and large doses of glucose.
    Tsujimoto T; Takano M; Nishiofuku M; Yoshiji H; Matsumura Y; Kuriyama S; Uemura M; Okamoto S; Fukui H
    Intern Med; 2006; 45(7):469-73. PubMed ID: 16679704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problem based review: the patient who has taken an overdose of long-acting insulin analogue.
    Eldred AE; Mustafa OG; Hunt KF; Whitelaw BC
    Acute Med; 2013; 12(3):167-72. PubMed ID: 24098877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 1 diabetes mellitus and the use of flexible insulin regimens.
    Hirsch IB
    Am Fam Physician; 1999 Nov; 60(8):2343-52, 2355-6. PubMed ID: 10593324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of a 40 IU/ml porcine lente insulin preparation in diabetic cats: findings during the first week and after 5 or 9 weeks of therapy.
    Martin GJ; Rand JS
    J Feline Med Surg; 2001 Mar; 3(1):23-30. PubMed ID: 11716627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving glycemic control in the cardiothoracic intensive care unit: clinical experience in two hospital settings.
    Goldberg PA; Sakharova OV; Barrett PW; Falko LN; Roussel MG; Bak L; Blake-Holmes D; Marieb NJ; Inzucchi SE
    J Cardiothorac Vasc Anesth; 2004 Dec; 18(6):690-7. PubMed ID: 15650975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.